Literature DB >> 30429351

Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.

Eckart Meese1, Friedrich A Grässer2, Hiresh Ayoubian3,1, Nicole Ludwig1, Tobias Fehlmann4, Jennifer Menegatti3, Laura Gröger1, Eleni Anastasiadou5, Pankaj Trivedi6, Andreas Keller1,4.   

Abstract

Diffuse large B-cell lymphoma (DLBCL) is an aggressive lymphoid tumor which is occasionally Epstein-Barr virus (EBV) positive and is further subtyped as activated B-cell DLBCL (ABC-DLBCL) and germinal center B-cell DLBCL (GCB-DLBCL), which has implications for prognosis and treatment. We performed Ago2 RNA immunoprecipitation followed by high-throughput RNA sequencing (Ago2-RIP-seq) to capture functionally active microRNAs (miRNAs) in EBV-negative ABC-DLBCL and GCB-DLBCL cell lines and their EBV-infected counterparts. In parallel, total miRNA profiles of these cells were determined to capture the cellular miRNA profile for comparison with the functionally active profile. Selected miRNAs with differential abundances were validated using real-time quantitative PCR (RT-qPCR) and Northern blotting. We found 6 miRNAs with differential abundances (2 upregulated and 4 downregulated miRNAs) between EBV-negative and -positive ABC-DLBCL cells and 12 miRNAs with differential abundances (3 upregulated and 9 downregulated miRNAs) between EBV-negative and -positive GCB-DLBCL cells. Eight and twelve miRNAs were confirmed using RT-qPCR in ABC-DLBCL and GCB-DLBCL cells, respectively. Selected miRNAs were analyzed in additional type I/II versus type III EBV latency DLBCL cell lines. Furthermore, upregulation of miR-221-3p and downregulation of let7c-5p in ABC-DLBCL cells and upregulation of miR-363-3p and downregulation of miR-423-5p in GCB-DLBCL cells were verified using RIP-Northern blotting. Our comprehensive sequence analysis of the DLBCL miRNA profiles identified sets of deregulated miRNAs by Ago2-RIP-seq. Our Ago2-IP-seq miRNA profile could be considered an important data set for the detection of deregulated functionally active miRNAs in DLBCLs and could possibly lead to the identification of miRNAs as biomarkers for the classification of DLBCLs or even as targets for personalized targeted treatment.IMPORTANCE Diffuse large B-cell lymphoma (DLBCL) is a highly aggressive tumor of lymphoid origin which is occasionally Epstein-Barr virus (EBV) positive. MicroRNAs are found in most multicellular organisms and even in viruses such as EBV. They regulate the synthesis of proteins by binding to their cognate mRNA. MicroRNAs are tethered to their target mRNAs by "Argonaute" proteins. Here we compared the overall miRNA content of the Ago2 complex by differential loading to the overall content of miRNAs in two DLBCL cell lines and their EBV-converted counterparts. In all cell lines, the Ago2 load was different from the overall expression of miRNAs. In addition, the loading of the Ago2 complex was changed upon infection with EBV. This indicates that the virus not only changes the overall content of miRNAs but also influences the expression of proteins by affecting the Ago complexes.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  Ago-IP; Argonaute; DLBCL; Epstein-Barr virus; microRNA; profiling; sequencing

Mesh:

Substances:

Year:  2019        PMID: 30429351      PMCID: PMC6340033          DOI: 10.1128/JVI.01297-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

Review 1.  EBNA2 and Its Coactivator EBNA-LP.

Authors:  Bettina Kempkes; Paul D Ling
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

2.  Yin and yang: cancer-implicated miRNAs that have it both ways.

Authors:  Jason T Huse; Eric C Holland
Journal:  Cell Cycle       Date:  2009-11-15       Impact factor: 4.534

3.  miR-29a and miR-142-3p downregulation and diagnostic implication in human acute myeloid leukemia.

Authors:  Fang Wang; Xiao-Shuang Wang; Gui-Hua Yang; Peng-Fei Zhai; Zhen Xiao; Liang-Yu Xia; Li-Rong Chen; Yu Wang; Xiao-Zhong Wang; Lai-Xi Bi; Nian Liu; Yang Yu; Da Gao; Bin-Tao Huang; Jing Wang; Dao-Bin Zhou; Jia-Nan Gong; Hua-Lu Zhao; Xiu-Hua Bi; Jia Yu; Jun-Wu Zhang
Journal:  Mol Biol Rep       Date:  2011-06-16       Impact factor: 2.316

4.  Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis.

Authors:  Aya Shinozaki-Ushiku; Akiko Kunita; Maya Isogai; Takashi Hibiya; Tetsuo Ushiku; Kenzo Takada; Masashi Fukayama
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

5.  MiR-142 acts as a tumor suppressor in osteosarcoma cell lines by targeting Rac1.

Authors:  Zhonghui Zheng; Muliang Ding; Jiangdong Ni; Deye Song; Jun Huang; Junjie Wang
Journal:  Oncol Rep       Date:  2014-12-22       Impact factor: 3.906

Review 6.  Epstein Barr virus-associated tumours: an update for the attention of the working pathologist.

Authors:  H-J Delecluse; R Feederle; B O'Sullivan; P Taniere
Journal:  J Clin Pathol       Date:  2007-09-14       Impact factor: 3.411

7.  Overexpression of miR-1260b in Non-small Cell Lung Cancer is Associated with Lymph Node Metastasis.

Authors:  Limin Xu; Liqin Li; Jing Li; Hongwei Li; Qibin Shen; Jinliang Ping; Zhihong Ma; Jing Zhong; Licheng Dai
Journal:  Aging Dis       Date:  2015-11-17       Impact factor: 6.745

8.  MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression.

Authors:  Irena Ivanovska; Alexey S Ball; Robert L Diaz; Jill F Magnus; Miho Kibukawa; Janell M Schelter; Sumire V Kobayashi; Lee Lim; Julja Burchard; Aimee L Jackson; Peter S Linsley; Michele A Cleary
Journal:  Mol Cell Biol       Date:  2008-01-22       Impact factor: 4.272

9.  Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status.

Authors:  Petra Leidinger; Martin Hart; Christina Backes; Stefanie Rheinheimer; Bastian Keck; Bernd Wullich; Andreas Keller; Eckart Meese
Journal:  Tumour Biol       Date:  2016-01-29

10.  MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma.

Authors:  Wiyada Kwanhian; Dido Lenze; Julia Alles; Natalie Motsch; Stephanie Barth; Celina Döll; Jochen Imig; Michael Hummel; Marianne Tinguely; Pankaj Trivedi; Viraphong Lulitanond; Gunter Meister; Christoph Renner; Friedrich A Grässer
Journal:  Cancer Med       Date:  2012-09-18       Impact factor: 4.452

View more
  8 in total

Review 1.  A review on EBV encoded and EBV-induced host microRNAs expression profile in different lymphoma types.

Authors:  Saber Soltani; Armin Zakeri; Alireza Tabibzadeh; Amir Mohammad Zakeri; Milad Zandi; Saba Siavoshi; Saba Seifpour; Abbas Farahani
Journal:  Mol Biol Rep       Date:  2021-02-01       Impact factor: 2.316

2.  The hypoxia-induced changes in miRNA-mRNA in RNA-induced silencing complexes and HIF-2 induced miRNAs in human endothelial cells.

Authors:  Adrianna Moszyńska; Maciej Jaśkiewicz; Marcin Serocki; Aleksandra Cabaj; David K Crossman; Sylwia Bartoszewska; Magdalena Gebert; Michał Dąbrowski; James F Collawn; Rafal Bartoszewski
Journal:  FASEB J       Date:  2022-07       Impact factor: 5.834

Review 3.  Next-generation sequencing: A new avenue to understand viral RNA-protein interactions.

Authors:  Yiyang Zhou; Stephanea L Sotcheff; Andrew L Routh
Journal:  J Biol Chem       Date:  2022-04-09       Impact factor: 5.486

4.  Epstein-Barr Virus BGLF2 commandeers RISC to interfere with cellular miRNA function.

Authors:  Ashley M Campbell; Carlos F De La Cruz-Herrera; Edyta Marcon; Jack Greenblatt; Lori Frappier
Journal:  PLoS Pathog       Date:  2022-01-10       Impact factor: 6.823

5.  Differential expression of miRNAs as biomarkers for predicting the outcomes of diffuse large B-cell lymphoma patients.

Authors:  Maogui Hu; Xinchen Wang; Ning Liu; Kaiyang Ding; Guihong Zhang; Xiaosi Liu
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

6.  Differential expression analysis comparing EBV uninfected to infected human cell lines identifies induced non-micro small non-coding RNAs.

Authors:  Lumbini I Moss; Van S Tompkins; Walter N Moss
Journal:  Noncoding RNA Res       Date:  2020-02-21

7.  Upregulation of miR‑423 improves autologous vein graft restenosis via targeting ADAMTS‑7.

Authors:  Wenjun Ren; Liwen Liang; Yongwu Li; Fei-Yu Wei; Ninghui Mu; Libin Zhang; Wei He; Yu Cao; Da Xiong; Hongrong Li
Journal:  Int J Mol Med       Date:  2019-12-05       Impact factor: 4.101

Review 8.  The Role of Noncoding RNAs in B-Cell Lymphoma.

Authors:  Jingwen Li; Jing Zou; Xiaoyue Wan; Chunyan Sun; Fei Peng; Zhangbo Chu; Yu Hu
Journal:  Front Oncol       Date:  2020-10-23       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.